Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03573271 · ClinicalTrials.gov registry record · NA
Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles
A NA study, sponsored by Cytrellis Biosystems.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03573271: Completed NA study, sponsored by Cytrellis Biosystems.
NCT03573271 is a NA study that has completed, run by Cytrellis Biosystems. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03573271, a NA study, has completed, sponsored by Cytrellis Biosystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Study evaluating the safety and efficacy of a micro-coring device for the treatment of moderate to severe cheek wrinkles.
Primary Outcome
Assess level of wrinkle improvement from the baseline to 90 day post treatment an Independent Reviewer(s) using the Lemperle Wrinkle Severity Scale
Interventions
- DEVICE MCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2019-02-28 |
| Phase | NA |
What the finished NCT03573271 record still lists
NCT03573271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which MCD is the first listed.
NCT03573271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03573271 about?
NCT03573271 is a clinical study titled "Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles". Study evaluating the safety and efficacy of a micro-coring device for the treatment of moderate to severe cheek wrinkles.
What is the current status of trial NCT03573271?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-03-26. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03573271?
The interventions under investigation include: MCD (DEVICE).
Who is sponsoring clinical trial NCT03573271?
This trial is sponsored by Cytrellis Biosystems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03573271's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI